Baumann, M H; Kallijarvi, J; Lankinen, H et al. (2000) Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochem J 349:77-84
|
Soto, C; Golabek, A; Wisniewski, T et al. (1996) Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro. Neuroreport 7:721-5
|
Palha, J A; Moreira, P; Wisniewski, T et al. (1996) Transthyretin gene in Alzheimer's disease patients. Neurosci Lett 204:212-4
|
Wisniewski, T; Frangione, B (1996) Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiol Exp (Wars) 56:267-79
|
Golabek, A A; Soto, C; Vogel, T et al. (1996) The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. J Biol Chem 271:10602-6
|
Perini, F; Vidal, R; Ghetti, B et al. (1996) PrP27-30 is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun 223:572-7
|
Perini, F; Frangione, B; Prelli, F (1996) Prion protein released by platelets. Lancet 347:1635-6
|
Wisniewski, T; Lalowski, M; Baumann, M et al. (1996) HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions. Neuroreport 7:667-71
|
Lalowski, M; Golabek, A; Lemere, C A et al. (1996) The ""nonamyloidogenic"" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid. J Biol Chem 271:33623-31
|
Baumann, M H; Wisniewski, T; Levy, E et al. (1996) C-terminal fragments of alpha- and beta-tubulin form amyloid fibrils in vitro and associate with amyloid deposits of familial cerebral amyloid angiopathy, British type. Biochem Biophys Res Commun 219:238-42
|
Showing the most recent 10 out of 22 publications